Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Judith Varner

    TitleProfessor
    SchoolUniversity of California, San Diego
    DepartmentPathology
    Address9500 Gilman Drive #0819
    CA La Jolla 92093
    Phone858-822-0086
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Research Interests
      Mechanisms regulating tumor angiogenesis, lymphangiogenesis, inflammation and metastasis.

      Education and Training
      AB - Chemistry, Duke University, Durham, NC - 1976-1980
      Fulbright Fellowship - University of Basel, Basel, Switzerland - 1980-1981
      PhD - University of Basel, Basel, Switzerland - 1981-1988
      Postdoctoral fellow - Dept. Molecular Genetics, Tampa Bay Research Institute - 1988-1990
      Postdoctoral fellow - Dept. Pharmacology, University of North Carolina, Chapel Hill - 1991-1993


      Collapse Research 
      Collapse Research Activities and Funding
      Role of PI3Kinase Gamma in Tumor Progression and Metastasis
      NIH/NCI R01CA167426Apr 1, 2012 - Mar 31, 2018
      Role: Principal Investigator
      The lymph node microenvionment in tumor metastasis
      NIH/NCI R01CA126820Jan 7, 2008 - Dec 31, 2014
      Role: Principal Investigator
      Negative Regulation of Cell Migration by PKA
      NIH/NCI R01CA098048Jun 25, 2003 - Apr 30, 2009
      Role: Principal Investigator
      Fibronectin-binding integrins in angiogenesis
      NIH/NCI R01CA083133Sep 1, 1999 - Jun 30, 2011
      Role: Principal Investigator
      INTEGRIN A5B1 AND TUMOR CELL GROWTH
      NIH/NCI R01CA071619Apr 1, 1997 - Jan 31, 2003
      Role: Principal Investigator

      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Websites
      Collapse In The News

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, Schmid MC, Pink M, Winkler DG, Rausch M, Palombella VJ, Kutok J, McGovern K, Frazer KA, Wu X, Karin M, Sasik R, Cohen EE, Varner J. Corrigendum: PI3K? is a molecular switch that controls immune suppression. Nature. 2016 Dec 14. PMID: 27974794.
        View in: PubMed
      2. Megan M. Kaneda, Karen S. Messer, Natacha Ralainirina, Hongying Li, Chris Leem, Sara Gorjestani, Gyunghwi Woo, Abraham V. Nguyen, Camila C. Figueiredo, Philippe Foubert, Michael C. Schmid, Melissa Pink, David G. Winkler, Matthew Rausch, Vito J. Palombella, Jeffery Kutok, Karen McGovern, Kelly A. Frazer, Xuefeng Wu, Michael Karin, Roman Sasik, Ezra E. W. Cohen & Judith A. Varner. PI3K? is a molecular switch that controls immune suppression. Nature | Article Accelerated Article Preview . 2016.
      3. Kaneda MM, Messer KS, Ralainirina N, Li H, Leem C, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, Schmid MC, Pink M, Winkler DG, Rausch M, Palombella VJ, Kutok J, McGovern K, Frazer KA, Wu X, Karin M, Sasik R, Cohen EE, Varner J. PI3K? is a molecular switch that controls immune suppression. Nature. 2016 Sep 19. PMID: 27642729.
        View in: PubMed
      4. Kaneda MM, Cappello P, Nguyen AV, Ralainirina N, Hardamon CR, Foubert P, Schmid MC, Sun P, Mose E, Bouvet M, Lowy AM, Valasek MA, Sasik R, Novelli F, Hirsch E, Varner J. Macrophage PI3K? Drives Pancreatic Ductal Adenocarcinoma Progression. Cancer Discov. 2016 Aug; 6(8):870-85. PMID: 27179037.
        View in: PubMed
      5. Gunderson AJ, Kaneda MM, Tsujikawa T, Nguyen AV, Affara NI, Ruffell B, Gorjestani S, Liudahl SM, Truitt M, Olson P, Kim G, Hanahan D, Tempero MA, Sheppard B, Irving B, Chang BY, Varner J, Coussens LM. Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer. Cancer Discov. 2016 Mar; 6(3):270-85. PMID: 26715645; NIHMSID: NIHMS748240.
        View in: PubMed
      6. Young SA, McCabe KE, Bartakova A, Delaney J, Pizzo DP, Newbury RO, Varner J, Schlaepfer DD, Stupack DG. Integrin a4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCNlow Neuroblastoma. PLoS One. 2015; 10(5):e0120815. PMID: 25973900.
        View in: PubMed
      7. Garmy-Susini B, Avraamides CJ, Desgrosellier JS, Schmid MC, Foubert P, Ellies LG, Lowy AM, Blair SL, Vandenberg SR, Datnow B, Wang HY, Cheresh DA, Varner J. PI3Ka activates integrin a4ß1 to establish a metastatic niche in lymph nodes. Proc Natl Acad Sci U S A. 2013 May 28; 110(22):9042-7. PMID: 23671068.
        View in: PubMed
      8. Schmid MC, Franco I, Kang SW, Hirsch E, Quilliam LA, Varner J. PI3-kinase ? promotes Rap1a-mediated activation of myeloid cell integrin a4ß1, leading to tumor inflammation and growth. PLoS One. 2013; 8(4):e60226. PMID: 23565202.
        View in: PubMed
      9. Kato H, Liao Z, Mitsios JV, Wang HY, Deryugina EI, Varner J, Quigley JP, Shattil SJ. The primacy of ß1 integrin activation in the metastatic cascade. PLoS One. 2012; 7(10):e46576. PMID: 23056350.
        View in: PubMed
      10. Schmid MC, Varner J. Myeloid cells in tumor inflammation. Vasc Cell. 2012; 4(1):14. PMID: 22938502.
        View in: PubMed
      11. Foubert P, Varner J. Integrins in tumor angiogenesis and lymphangiogenesis. Methods Mol Biol. 2012; 757:471-86. PMID: 21909928.
        View in: PubMed
      12. Schmid MC, Avraamides CJ, Foubert P, Shaked Y, Kang SW, Kerbel RS, Varner J. Combined blockade of integrin-a4ß1 plus cytokines SDF-1a or IL-1ß potently inhibits tumor inflammation and growth. Cancer Res. 2011 Nov 15; 71(22):6965-75. PMID: 21948958.
        View in: PubMed
      13. Schmid MC, Avraamides CJ, Dippold HC, Franco I, Foubert P, Ellies LG, Acevedo LM, Manglicmot JR, Song X, Wrasidlo W, Blair SL, Ginsberg MH, Cheresh DA, Hirsch E, Field SJ, Varner J. Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3k?, a single convergent point promoting tumor inflammation and progression. Cancer Cell. 2011 Jun 14; 19(6):715-27. PMID: 21665146.
        View in: PubMed
      14. Yin X, Johns SC, Lawrence R, Xu D, Reddi K, Bishop JR, Varner J, Fuster MM. Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C). J Biol Chem. 2011 Apr 29; 286(17):14952-62. PMID: 21343305.
        View in: PubMed
      15. Jin H, Garmy-Susini B, Avraamides CJ, Stoletov K, Klemke RL, Varner J. A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting. Blood. 2010 Dec 16; 116(25):5773-83. PMID: 20826718.
        View in: PubMed
      16. Schmid MC, Varner J. Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation. J Oncol. 2010; 2010:201026. PMID: 20490273.
        View in: PubMed
      17. Garmy-Susini B, Avraamides CJ, Schmid MC, Foubert P, Ellies LG, Barnes L, Feral C, Papayannopoulou T, Lowy A, Blair SL, Cheresh D, Ginsberg M, Varner J. Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res. 2010 Apr 15; 70(8):3042-51. PMID: 20388801.
        View in: PubMed
      18. Schmid MC, Varner J. Circulating endothelial progenitor cells. Methods Mol Biol. 2009; 467:139-55. PMID: 19301669.
        View in: PubMed
      19. Avraamides CJ, Garmy-Susini B, Varner J. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer. 2008 Aug; 8(8):604-17. PMID: 18497750.
        View in: PubMed
      20. McElroy M, Hayashi K, Garmy-Susini B, Kaushal S, Varner J, Moossa AR, Hoffman RM, Bouvet M. Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J Surg Res. 2009 Jan; 151(1):68-73. PMID: 18599080.
        View in: PubMed
      21. Schmid MC, Varner J. Chapter 15. Methods to study myeloid cell roles in angiogenesis. Methods Enzymol. 2008; 445:343-71. PMID: 19022067.
        View in: PubMed
      22. Garmy-Susini B, Varner J. Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res Biol. 2008; 6(3-4):155-63. PMID: 19093788.
        View in: PubMed
      23. Varner J. Stem cells and neurogenesis in tumors. Prog Exp Tumor Res. 2007; 39:122-9. PMID: 17314505.
        View in: PubMed
      24. Garmy-Susini B, Makale M, Fuster M, Varner J. Methods to study lymphatic vessel integrins. Methods Enzymol. 2007; 426:415-38. PMID: 17697894.
        View in: PubMed
      25. Varner J. The sticky truth about angiogenesis and thrombospondins. J Clin Invest. 2006 Dec; 116(12):3111-3. PMID: 17143327.
        View in: PubMed
      26. Schmid MC, Varner J. Myeloid cell trafficking and tumor angiogenesis. Cancer Lett. 2007 May 18; 250(1):1-8. PMID: 17049723.
        View in: PubMed
      27. Lucidarme O, Kono Y, Corbeil J, Choi SH, Golmard JL, Varner J, Mattrey RF. Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model. Radiology. 2006 Jun; 239(3):730-9. PMID: 16714458.
        View in: PubMed
      28. Garmy-Susini B, Varner J. Circulating endothelial progenitor cells. Br J Cancer. 2005 Oct 17; 93(8):855-8. PMID: 16189517.
        View in: PubMed
      29. Lucidarme O, Nguyen T, Kono Y, Corbeil J, Choi SH, Varner J, Mattrey RF. Angiogenesis model for ultrasound contrast research: exploratory study. Acad Radiol. 2004 Jan; 11(1):4-12. PMID: 14746396.
        View in: PubMed
      30. Boudreau NJ, Varner J. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem. 2004 Feb 6; 279(6):4862-8. PMID: 14610084.
        View in: PubMed
      31. Zhong J, Eliceiri B, Stupack D, Penta K, Sakamoto G, Quertermous T, Coleman M, Boudreau N, Varner J. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest. 2003 Jul; 112(1):30-41. PMID: 12840057.
        View in: PubMed
      32. Kim S, Bakre M, Yin H, Varner J. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J Clin Invest. 2002 Oct; 110(7):933-41. PMID: 12370271.
        View in: PubMed
      33. Bakre MM, Zhu Y, Yin H, Burton DW, Terkeltaub R, Deftos LJ, Varner J. Parathyroid hormone-related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor. Nat Med. 2002 Sep; 8(9):995-1003. PMID: 12185361.
        View in: PubMed
      34. Ojo-Amaize EA, Nchekwube EJ, Cottam HB, Bai R, Verdier-Pinard P, Kakkanaiah VN, Varner J, Leoni L, Okogun JI, Adesomoju AA, Oyemade OA, Hamel E. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action. Cancer Res. 2002 Jul 15; 62(14):4007-14. PMID: 12124334.
        View in: PubMed
      35. Aoka Y, Johnson FL, Penta K, Hirata Ki K, Hidai C, Schatzman R, Varner J, Quertermous T. The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation. Microvasc Res. 2002 Jul; 64(1):148-61. PMID: 12074641.
        View in: PubMed
      36. Kim S, Harris M, Varner J. Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J Biol Chem. 2000 Oct 27; 275(43):33920-8. PMID: 10944524.
        View in: PubMed
      37. Kim S, Bell K, Mousa SA, Varner J. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol. 2000 Apr; 156(4):1345-62. PMID: 10751360.
        View in: PubMed
      38. Penta K, Varner J, Liaw L, Hidai C, Schatzman R, Quertermous T. Del1 induces integrin signaling and angiogenesis by ligation of alphaVbeta3. J Biol Chem. 1999 Apr 16; 274(16):11101-9. PMID: 10196194.
        View in: PubMed
      39. Varner J, Nakada MT, Jordan RE, Coller BS. Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro). Angiogenesis. 1999; 3(1):53-60. PMID: 14517444.
        View in: PubMed
      40. Varner J. The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis. EXS. 1997; 79:361-90. PMID: 9002227.
        View in: PubMed
      41. Varner J, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol. 1996 Oct; 8(5):724-30. PMID: 8939661.
        View in: PubMed
      42. Varner J. Isolation of a sponge-derived extracellular matrix adhesion protein. J Biol Chem. 1996 Jul 5; 271(27):16119-25. PMID: 8663195.
        View in: PubMed
      43. Varner J, Cheresh DA. Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv Oncol. 1996; 69-87. PMID: 8791129.
        View in: PubMed
      44. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner J, Cheresh DA. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995 Dec 1; 270(5241):1500-2. PMID: 7491498.
        View in: PubMed
      45. Varner J, Brooks PC, Cheresh DA. REVIEW: the integrin alpha V beta 3: angiogenesis and apoptosis. Cell Adhes Commun. 1995 Nov; 3(4):367-74. PMID: 8821037.
        View in: PubMed
      46. Varner J. Cell adhesion in sponges: potentiation by a cell surface 68 kDa proteoglycan-binding protein. J Cell Sci. 1995 Sep; 108 ( Pt 9):3119-26. PMID: 8537451.
        View in: PubMed
      47. Varner J, Emerson DA, Juliano RL. Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell. 1995 Jun; 6(6):725-40. PMID: 7579691.
        View in: PubMed
      48. Juliano RL, Varner J. Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol. 1993 Oct; 5(5):812-8. PMID: 8240825.
        View in: PubMed
      49. Litman GW, Amemiya CT, Harding FA, Haire RN, Hinds KR, Litman RT, Ohta Y, Shamblott MJ, Varner J. Evolutionary development of immunoglobulin gene diversity. Adv Exp Med Biol. 1991; 292:11-7. PMID: 1950762.
        View in: PubMed
      50. Varner J, Burger MM, Kaufman JF. Two cell surface proteins bind the sponge Microciona prolifera aggregation factor. J Biol Chem. 1988 Jun 15; 263(17):8498-508. PMID: 3372540.
        View in: PubMed